Paralysis
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
NeuroTriggerIsrael - Tel Aviv
1 programNeurotrigger Basic. eye blinking stimulatorN/A1 trial
Active Trials
Angeles TherapeuticsCA - Los Angeles
1 programTranscutaneous Electrical Spinal Cord StimulationN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
NeuroTriggerNeurotrigger Basic. eye blinking stimulator
Angeles TherapeuticsTranscutaneous Electrical Spinal Cord Stimulation
Clinical Trials (2)
Total enrollment: 18 patients across 2 trials
Evaluate the Usability of the Neuro-trigger Artificial Eye Blinking Stimulation Device in Patients With Paralysis of the Facial Nerve.
Start: Oct 2023Est. completion: Sep 202411 patients
N/ACompleted
Restoring Arm and Hand Function With Non-invasive Spinal Stimulation
Start: Apr 2016Est. completion: Dec 20167 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.